This is an old revision of this page, as edited by Beetstra (talk | contribs) at 20:11, 10 November 2011 (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEMBL').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 20:11, 10 November 2011 by Beetstra (talk | contribs) (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEMBL').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundClinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a600042 |
Pregnancy category |
|
Routes of administration | Intravenous |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H36O5 |
Molar mass | 368.508 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Carboprost (INN, trade names for the tromethamine salts Hemabate, Tham) is a synthetic prostaglandin analogue of PGF2α (specifically, it is 15-methyl-PGF2α) with oxytocic properties.
Carboprost induces contractions and can trigger abortion in early pregnancy. It also reduces postpartum bleeding.
Indication
Used in postpartum hemorrhage caused by uterine atony not controlled by other methods.
Unlabeled use:
- Hemorrhagic Cystitis
- PID
Contraindication
Contraindicated in severe cardiovascular, renal, and hepatic disease, also contraindicated in Pelvic Inflammatory Disease. Exert caution in asthmatic patients.
Precautions
- asthma
- anemia
- jaundice
- diabetes mellitus
- seizure disorders
- past uterine surgery
Adverse Effects
- diarrhea (most common, may be sudden in onset)
- fever
- chills
- nausea/vomiting
References
External links
- Carboprost at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- Indman P (2004). "Use of carboprost to facilitate hysteroscopic resection of submucous myomas". J Am Assoc Gynecol Laparosc. 11 (1): 68–72. doi:10.1016/S1074-3804(05)60014-X. PMID 15104835.
- Vukelić J (2001). "Second trimester pregnancy termination in primigravidas by double application of dinoprostone gel and intramuscular administration of carboprost tromethamine". Med Pregl. 54 (1–2): 11–6. PMID 11436877.
- Ippoliti C, Przepiorka D, Mehra R, Neumann J, Wood J, Claxton D, Gajewski J, Khouri I, van Besien K, Andersson B (1995). "Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation". Urology. 46 (6): 811–5. doi:10.1016/S0090-4295(99)80349-5. PMID 7502421.
{{cite journal}}
: CS1 maint: multiple names: authors list (link)
Eicosanoids | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Precursor | |||||||||||||||
Prostanoids |
| ||||||||||||||
Leukotrienes (LT) |
| ||||||||||||||
Eoxins (EX) |
| ||||||||||||||
Nonclassic |
| ||||||||||||||
By function |
Uterotonics/labor inducers/oxytocics (G02A) | |||||
---|---|---|---|---|---|
Cervical ripening |
| ||||
Contraction induction | |||||
|
This drug article relating to the genito-urinary system is a stub. You can help Misplaced Pages by expanding it. |